-
Likelihood of Approval and Phase Transition Success Rate Model - ABA-101 in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABA-101 in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABA-101 in Secondary Progressive Multiple Sclerosis (SPMS) Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Ensitrelvir Fumarate in Post-Acute Sequelae of COVID 2019 (PASC or Long COVID)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ensitrelvir Fumarate in Post-Acute Sequelae of COVID 2019 (PASC or Long COVID) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ensitrelvir Fumarate in...
-
Likelihood of Approval and Phase Transition Success Rate Model - (Lidocaine + Oxybutynin) SR in Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Lidocaine + Oxybutynin) SR in Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Lidocaine + Oxybutynin)...
-
Likelihood of Approval and Phase Transition Success Rate Model - IMC-2019 in Bone Fracture
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IMC-2019 in Bone Fracture report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IMC-2019 in Bone Fracture Drug Details: IMC-2019 is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - EB-105 in Diabetic Macular Edema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EB-105 in Diabetic Macular Edema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EB-105 in Diabetic Macular Edema Drug Details: EB-105 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - (Hyaluronidase (recombinant Human) + Pembrolizumab) in Metastatic Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Hyaluronidase (recombinant Human) + Pembrolizumab) in Metastatic Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Hyaluronidase (recombinant Human) + Pembrolizumab)...
-
Likelihood of Approval and Phase Transition Success Rate Model - Telisotuzumab Adizutecan in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Telisotuzumab Adizutecan in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Telisotuzumab Adizutecan in Metastatic Hepatocellular Carcinoma (HCC) Drug...
-
Likelihood of Approval and Phase Transition Success Rate Model - Alphaf-002 in Castration-Resistant Prostate Cancer (CRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Alphaf-002 in Castration-Resistant Prostate Cancer (CRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alphaf-002 in Castration-Resistant Prostate Cancer (CRPC) Drug Details: Alphaf-002...
-
Likelihood of Approval and Phase Transition Success Rate Model - (AR-17043 + Latanoprost) in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (AR-17043 + Latanoprost) in Ocular Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (AR-17043 + Latanoprost) in Ocular Hypertension Drug Details: The...
-
Likelihood of Approval and Phase Transition Success Rate Model - GRT-6018 in Unspecified Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GRT-6018 in Unspecified Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GRT-6018 in Unspecified Pain Drug Details: GRT-6018 is under development for...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.